CRIS Current Research Information System

DE LORENZO, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.468
NA - Nord America 3.123
EU - Europa 2.123
AF - Africa 244
SA - Sud America 132
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.079
VN - Vietnam 1.022
SG - Singapore 913
CN - Cina 894
IT - Italia 538
GB - Regno Unito 302
SE - Svezia 292
DE - Germania 231
HK - Hong Kong 163
KR - Corea 140
IN - India 129
NL - Olanda 121
FR - Francia 105
IE - Irlanda 102
CI - Costa d'Avorio 94
CH - Svizzera 90
RU - Federazione Russa 88
BR - Brasile 83
FI - Finlandia 68
SC - Seychelles 46
TG - Togo 39
CA - Canada 31
JP - Giappone 31
ZA - Sudafrica 30
AT - Austria 29
JO - Giordania 28
UA - Ucraina 26
BG - Bulgaria 22
NG - Nigeria 21
ID - Indonesia 20
TR - Turchia 20
AR - Argentina 18
BE - Belgio 18
EE - Estonia 18
PH - Filippine 18
GR - Grecia 16
PL - Polonia 16
BD - Bangladesh 14
TW - Taiwan 12
IQ - Iraq 11
PK - Pakistan 11
PS - Palestinian Territory 10
LT - Lituania 8
RO - Romania 8
EC - Ecuador 7
ES - Italia 7
MX - Messico 7
SA - Arabia Saudita 7
CL - Cile 6
TH - Thailandia 6
VE - Venezuela 6
EG - Egitto 5
UZ - Uzbekistan 5
NI - Nicaragua 4
PE - Perù 4
CO - Colombia 3
HR - Croazia 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
BO - Bolivia 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DK - Danimarca 1
FJ - Figi 1
HT - Haiti 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TV - Tuvalu 1
Totale 9.095
Salva come PNG Salva come JPEG
Città #
Singapore 654
Ashburn 319
Hefei 318
Dallas 292
Southend 255
Chandler 238
Hanoi 228
Fairfield 225
Ho Chi Minh City 219
San Jose 173
Dong Ket 162
Hong Kong 148
Woodbridge 128
Houston 124
Seoul 121
Dublin 102
Wilmington 101
Beijing 98
Abidjan 94
Bologna 93
Seattle 93
Santa Clara 89
Bern 82
Princeton 82
Cambridge 77
Ann Arbor 75
Boardman 62
Helsinki 62
New York 58
Council Bluffs 48
Da Nang 44
Frankfurt am Main 42
Lauterbourg 42
Los Angeles 41
Rome 41
Turin 40
Lomé 39
Nanjing 35
Milan 33
Amman 28
Berlin 28
Haiphong 28
Bengaluru 27
Tokyo 25
Redondo Beach 23
Westminster 23
Buffalo 22
Sofia 22
San Diego 21
Redmond 18
Abeokuta 17
London 17
Guangzhou 16
Shanghai 16
Toronto 16
Vienna 16
Brussels 15
Padova 15
São Paulo 15
Tongling 15
Chicago 14
Ravenna 13
Jakarta 12
Munich 12
Warsaw 12
Düsseldorf 11
Jinan 11
Redwood City 11
Shenyang 11
Bến Tre 10
Can Tho 10
Changsha 10
Des Moines 10
Florence 10
Ninh Bình 10
Amsterdam 9
Biên Hòa 9
Groningen 9
Montreal 9
Olalla 9
Orem 9
The Dalles 9
Ankara 8
Bremen 8
Halhul 8
Hải Dương 8
Istanbul 8
Long Xuyen 8
Nuremberg 8
Saint Petersburg 8
Vũng Tàu 8
Wuhan 8
Falkenstein 7
Forlì 7
Jacksonville 7
Medford 7
Norwalk 7
Torino 7
Tân Tiến 7
Bình Phước 6
Totale 5.965
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 451
Adjuvant treatment in biliary tract cancer 341
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 301
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 296
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 276
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 259
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 245
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 238
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 230
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 226
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 225
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 209
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 208
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 207
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 207
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 204
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis 196
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis 194
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis 192
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 190
In Reply 188
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 184
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 184
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma 181
Should patients on levothyroxine therapy be screened for pancreatic cancer? 180
Immunotherapy with checkpoint inhibitors for hepatocellular carcinoma: Where are we now? 177
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 176
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 175
Cholangiocarcinoma: From risk to prevention? 172
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma 171
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 166
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster 156
Treatment of combined hepatocellular and cholangiocarcinoma 154
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 150
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 150
Adjuvant Treatment and Follow-up Strategies 148
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 140
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? 140
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma 130
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 127
Trend of rifampicin resistant, MDR and XDR tuberculosis in Italy, 2009–2016 123
Regorafenib for the treatment of hepatocellular carcinoma 122
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 118
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role 116
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 107
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development 102
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? 95
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials 93
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 78
null 75
Microbiota, NASH, HCC and the potential role of probiotics 63
null 56
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab 33
Totale 9.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 0 0 0 0 41 28 199
2021/2022961 112 46 46 64 74 29 30 67 84 61 219 129
2022/20231.180 114 169 56 115 84 77 46 68 207 58 60 126
2023/2024327 34 51 16 28 16 69 13 19 17 26 21 17
2024/20251.496 68 161 145 89 144 53 122 110 49 150 121 284
2025/20263.701 374 432 539 282 319 172 604 102 644 233 0 0
Totale 9.325